Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY8XW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,600
Award facts
- Contract value 100% obligated
- $2,599.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,599.65 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen (0.5 ml), a glucagon-like peptide-1 receptor agonist used for weight management and diabetes treatment. The award, issued on January 28, 2026, with a completion date of January 29, 2026, represents a firm fixed-price purchase under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains and will fulfill this order from its corporate office location.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 31, 2031. This comprehensive IDC enables the company to supply a wide range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military treatment facilities, veteran healthcare programs, and other federal medical institutions globally. The company's extensive portfolio of federal contracts demonstrates its established capability to efficiently fulfill government requirements for essential medications across multiple therapeutic domains through competitive, firm fixed-price contracting arrangements.
Quick answers
Who was awarded contract SPE2DR26FY8XW?
SPE2DR26FY8XW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FY8XW worth?
The government has obligated $2,600 on SPE2DR26FY8XW.
Is contract SPE2DR26FY8XW an order under another contract?
Yes. SPE2DR26FY8XW is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8XW competed?
The extent of competition for SPE2DR26FY8XW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award